Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.150 CAD | +5.50% |
|
-5.74% | -48.66% |
07:47am | Curaleaf Brief: Appointing Rahul Pinto to Newly Created Role of President, Effective Immediately | MT |
06-13 | Curaleaf Holdings, Inc. - Shareholder/Analyst Call |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|
Medicinal Chemicals and Botanical Products | |||||||||
Cultivation, Production, Distribution, and Sale of Cannabis | - | - | 1.34B | 1.35B | 1.34B | ||||
Total Assets | - | - | 3.4B | 3.1B | 2.95B | ||||
Interest Expense | - | - | -93.33M | -100M | -101M | ||||
Income Tax Expense | - | - | 151M | 115M | 98.59M | ||||
CAPEX | - | - | -138M | -65.45M | -93.15M | ||||
EBT | - | - | -226M | -124M | -118M | ||||
Gross Profit | - | - | 579M | 614M | 639M | ||||
D&A | - | - | 176M | 212M | 250M | ||||
Operating Income | - | - | -12.37M | 42.88M | 20.2M | ||||
Net Income | - | - | -370M | -281M | -215M | ||||
Cannabis | 586M | 1.21B | - | - | - | ||||
Total Assets | 2.11B | 3.01B | - | - | - | ||||
Gross Profit | 350M | 685M | - | - | - | ||||
Operating Income | 122M | 259M | - | - | - | ||||
Net Income | 23.57M | 13.92M | - | - | - | ||||
Total Assets | 58.5M | 80.58M | - | - | - | ||||
Vitamins and Nutritional Supplements | |||||||||
Non-Cannabis | 40.42M | 2.32M | - | - | - | ||||
Total Assets | 212M | 174M | - | - | - | ||||
Gross Profit | 40.42M | 2.32M | - | - | - | ||||
Operating Income | -58.51M | -83.26M | - | - | - | ||||
Net Income | -84.9M | -123M | - | - | - |
Geographical Revenue Distribution History
Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|
United States | 627M | 1.21B | 1.3B | 1.29B | 1.24B | ||||
Total Assets | 2.39B | 3.26B | 2.46B | 2.35B | 2.19B | ||||
Interest Expense | -69M | -90.26M | - | - | - | ||||
Income Tax Expense | 83.37M | 174M | - | - | - | ||||
D&A | 87.46M | 132M | - | - | - | ||||
CAPEX | -126M | -172M | - | - | - | ||||
Gross Profit | 391M | 688M | 568M | 592M | 595M | ||||
Net Income | -61.74M | -102M | - | - | - | ||||
EBT | 22.04M | 64.8M | - | - | - | ||||
Operating Income | 63.68M | 176M | - | - | - | ||||
International | - | - | 34.43M | 61.01M | 106M | ||||
Total Assets | - | - | 330M | 329M | 334M | ||||
Gross Profit | - | - | 11.06M | 22.54M | 43.81M |
- Stock Market
- Equities
- CURA Stock
- Financials Curaleaf Holdings, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition